Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Search for New Physics in Jet Multiplicity Patterns of Multilepton Events at sqrt[s]=13  TeV.

Physical review letters·2025
Same author

[Advances in presbycusis animal model].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

Observation of Λ Hyperon Local Polarization in p-Pb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2025
Same author

Evidence for Similar Collectivity of High Transverse-Momentum Particles in p-Pb and Pb-Pb Collisions.

Physical review letters·2025
Same author

Search for a Neutral Gauge Boson with Nonuniversal Fermion Couplings in Vector Boson Fusion Processes in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2025

Related Experiment Video

Updated: Mar 2, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

SU-E-T-604: Inter Planner Dosimetric Variations in IMRT.

S Srivastava1,2,3, O Nohadani1,2,3, C Medawar1,2,3

  • 1Purdue University, Lafayette, In.

Medical Physics
|May 19, 2017
PubMed
Summary
This summary is machine-generated.

Inter-planner variations in Intensity-Modulated Radiation Therapy (IMRT) plans are significant, even with identical dose constraints. One planner achieved all dose criteria, suggesting a potential gold standard for IMRT quality assurance.

Keywords:
Data setsDosimetryIntensity modulated radiation therapyMedical treatment planning

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.0K

Related Experiment Videos

Last Updated: Mar 2, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.0K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiotherapy Planning

Background:

  • Intensity-Modulated Radiation Therapy (IMRT) is a precise radiotherapy technique.
  • Ensuring consistent treatment plan quality across different planners is crucial for patient safety and treatment efficacy.
  • Variations in treatment planning can arise from differences in planner experience and interpretation of dose constraints.

Purpose of the Study:

  • To investigate inter-planner variability in IMRT dosimetry using identical dose prescriptions.
  • To evaluate the quality of IMRT treatment plans by analyzing dose-volume histogram (DVH) data.
  • To identify factors contributing to variations in IMRT plan optimization.

Main Methods:

  • Five treatment planners utilized the Eclipse Treatment Planning System (TPS) with Varian accelerators.
  • A prostate cancer case with defined Planning Target Volume (PTV) and Organs at Risk (OARs) was used.
  • Planners applied identical dose constraints and inhomogeneity corrections; DVH and isodose distributions were compared.

Main Results:

  • Significant inter-planner variations were observed in IMRT plans, evident in DVH comparisons.
  • The D95-V95 dose criterion was identified as a critical clinical constraint.
  • Two planners failed to meet this criterion, while one planner successfully met all PTV and OAR dose criteria.

Conclusions:

  • Substantial inter-planner variations exist, even with standardized constraints, due to optimization algorithm convergence.
  • Controlling overdosing is achievable across planners.
  • Achieving all dose criteria is possible, as demonstrated by one planner, suggesting a potential benchmark for IMRT quality.